RecruitingNCT06346405
Central Serous Chorioretinopathy and Micropulse Laser Treatment
Studying Central serous chorioretinopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Intervention
- Subthreshold Micropulse Laser Treatment(other)
- Enrollment
- 36 enrolled
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2023 – 2027
Study locations (1)
- Fondazione Policlinico Agostino Gemelli, IRCCS, Roma, R, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06346405 on ClinicalTrials.govOther trials for Central serous chorioretinopathy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06527326the Study of the Association Between the Gut Microbiota and Central Serous ChorioretinopathySecond Affiliated Hospital, School of Medicine, Zhejiang University
- RECRUITINGNANCT05570591Subthreshold Nanosecond Laser for Non-resolving Central Serous ChorioretinopathyNova Eye Medical Pty Ltd.
- RECRUITINGNCT05589974Choroidal Blood Flow in Acute and Chronic Central Serous ChorioretinopathyHelse Stavanger HF